Literature DB >> 9732976

Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage.

J Bleier1, K P Vorderwinkler, J Falkensammer, P Mair, O Dapunt, B Puschendorf, J Mair.   

Abstract

We investigated the net myocardial release of creatine kinase isoenzyme MB (CKMB), myoglobin, cardiac troponin T (cTnT), cardiac troponin I (cTnI), and cardiac beta-type myosin heavy chain (beta-MHC) into the coronary circulation after cardioplegic cardiac arrest in humans. Cardiac markers were measured in paired arterial, central venous, and coronary sinus blood in 19 patients undergoing elective coronary artery bypass grafting (CABG) before aortic cross-clamping and 1, 5, 10, and 20 min after aortic declamping. cTnT and cTnI were released into the coronary sinus in parallel to each other and almost simultaneously to myoglobin and CKMB within 20 min of reperfusion. In contrast, no beta-MHC was released in the same patients during the study period. The average soluble cTnT and cTnI pools in right atrial appendages of 11 patients with right atrial and right ventricular pressures within reference values were comparable and were approximately 8% of total myocardial troponin content. The soluble beta-MHC pool was <0.1% in all patients. Our results demonstrate the impact of the different intracellular compartmention of regulatory and contractile proteins on their early release from damaged myocardium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732976

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  20 in total

Review 1.  Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?

Authors:  Thijs M H Eijsvogels; Antonio B Fernandez; Paul D Thompson
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I.

Authors:  Vishram Kedar; Holly McDonough; Ranjana Arya; Hui-Hua Li; Howard A Rockman; Cam Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

Review 3.  Perspective on the clinical application of troponin in heart failure and states of cardiac injury.

Authors:  Almasa Bass; J Herbert Patterson; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2009-04-05       Impact factor: 4.214

Review 4.  Making sense of high sensitivity troponin assays and their role in clinical care.

Authors:  Lori B Daniels
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

5.  Role of Cardiac Troponin Levels in Acute Heart Failure.

Authors:  Nicholas Wettersten; Alan Maisel
Journal:  Card Fail Rev       Date:  2015-10

6.  Do induced tachycardias within the scope of electrophysiological studies lead to elevated plasma troponin I levels?

Authors:  D Bandorski; H Bogossian; B Lemke; R Höltgen; M Wieczorek; M Brück
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

7.  Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study.

Authors:  Ragnhild Røysland; Gunnhild Kravdal; Arne Didrik Høiseth; Ståle Nygård; Pirouz Badr; Tor-Arne Hagve; Torbjørn Omland; Helge Røsjø
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

8.  Respiratory muscle injury, fatigue and serum skeletal troponin I in rat.

Authors:  Jeremy A Simpson; Jennifer Van Eyk; Steve Iscoe
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

9.  Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation.

Authors:  M H M Hessel; D E Atsma; E J M van der Valk; W H Bax; M J Schalij; A van der Laarse
Journal:  Pflugers Arch       Date:  2007-10-02       Impact factor: 3.657

Review 10.  The continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform.

Authors:  Daniel Soetkamp; Koen Raedschelders; Mitra Mastali; Kimia Sobhani; C Noel Bairey Merz; Jennifer Van Eyk
Journal:  Expert Rev Proteomics       Date:  2017-10-16       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.